runner
Well-Known Member
- Relationship to Diabetes
- Type 1.5 LADA
Hi, was anyone else with LADA using insulin, recommended to continue taking Metformin? I continued taking it, as recommended, although I take a lower dose, and recently came across this, from ActionLada:
Management of LADA:
There is no established management strategy for people diagnosed with LADA. The potential value of identifying this group at high risk of progression to insulin dependence includes:
• Avoidance of using metformin treatment given the theoretical associated risks of metformin in patients becoming insulin dependent.
• Early introduction of insulin therapy.
• Application of intervention trials to arrest or reverse the destructive disease process.
For those people diagnosed with diabetes in whom the primary defect is loss of insulin secretion, treatment should aim to restore islet insulin secretion. Therapy to prevent progression towards insulin dependency could include immunotherapy, insulin or oral hypoglycaemic drugs. The efficacy of sulphonylureas has not been formally tested but it is evident that they do not arrest progression to insulin dependency in subjects with LADA. Whether metformin is of benefit is unclear and the drug may be contraindicted in those with LADA as there is a theoretical risk of severe metabolic disturbance in individuals who progress to insulin dependency whilst on it.
the link to the info is here: http://www.actionlada.org/why/why.html
Management of LADA:
There is no established management strategy for people diagnosed with LADA. The potential value of identifying this group at high risk of progression to insulin dependence includes:
• Avoidance of using metformin treatment given the theoretical associated risks of metformin in patients becoming insulin dependent.
• Early introduction of insulin therapy.
• Application of intervention trials to arrest or reverse the destructive disease process.
For those people diagnosed with diabetes in whom the primary defect is loss of insulin secretion, treatment should aim to restore islet insulin secretion. Therapy to prevent progression towards insulin dependency could include immunotherapy, insulin or oral hypoglycaemic drugs. The efficacy of sulphonylureas has not been formally tested but it is evident that they do not arrest progression to insulin dependency in subjects with LADA. Whether metformin is of benefit is unclear and the drug may be contraindicted in those with LADA as there is a theoretical risk of severe metabolic disturbance in individuals who progress to insulin dependency whilst on it.
the link to the info is here: http://www.actionlada.org/why/why.html